Ventripoint Diagnostics Ltd., a developer of AI-powered cardiac imaging technology, has announced a strategic collaboration with the Ollie Hinkle Heart Foundation (OHHF) to expand access to advanced heart imaging for children and adults living with congenital and childhood-onset heart disease. The partnership, announced June 26, 2026, combines Ventripoint's VMS+™ platform with OHHF's Take Heart Collective Impact Model, which unites healthcare providers, innovators, researchers, families, and social partners including Jovie's Joy and Ella's Umbrella.
Under the collaboration, OHHF will provide initial financial support to place two VMS+™ systems within its healthcare partner network, along with funding for education, advocacy, research, and community engagement. Ventripoint's VMS+™ platform uses artificial intelligence and advanced cardiac modeling to generate accurate measurements of heart structure and function from standard echocardiograms, offering clinicians a more accessible and efficient way to enhance decision-making and monitor patients over time.
“Improving outcomes for people living with heart disease begins with access to accurate, timely, and affordable cardiac imaging,” said Joe Hostetter, Director of the Congenital Heart Disease Program at Ventripoint Diagnostics. “Together, we have an opportunity to expand access to advanced imaging solutions that help clinicians make more informed decisions and improve care throughout a patient’s journey.”
The collaboration is rooted in the lived experiences of families who have faced challenges in obtaining clear answers about their children's heart conditions. Katie Nesselbush, founder of Jovie's Joy and a social partner of OHHF, shared her perspective as a mother of a child with dilated cardiomyopathy. “Technologies like Ventripoint give physicians more information to guide care while reducing barriers and risk for families. Every parent wants confidence that they're making the best possible decisions for their child, and every child deserves access to the most advanced tools available,” she said.
Mark Hinkle, co-founder of OHHF, reflected on the loss of his son Ollie at 13 months old. “We can't change Ollie's story, and we can't bring Ella back. But we can honor them by ensuring more children have access to the technology, information, and treatment options they never had. That's the future we're building through the Take Heart Collective Impact Model.”
The partnership highlights how innovation and personal experience can drive change in pediatric cardiac care. By integrating Ventripoint's AI imaging with OHHF's collaborative network, the initiative aims to reduce disparities in access to advanced cardiac assessment. According to the press release, the VMS+ platform is designed to provide sophisticated cardiac insights from routine echocardiograms, potentially expanding the availability of gold-standard measurements previously limited to MRI.
Ventripoint's VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which delivers volumetric cardiac measurements equivalent to MRI. The platform is compatible with ultrasound systems from any vendor and holds regulatory approvals in the United States, Europe, and Canada. Further information about Ventripoint is available at www.ventripoint.com.
The Ollie Hinkle Heart Foundation focuses on transforming pediatric heart care through its Take Heart Collective Impact Model, which aligns healthcare systems, innovators, researchers, and families. More details can be found at www.ohhf.org.
This collaboration represents a step toward ensuring that children living with heart disease have access to accurate and less invasive diagnostic tools, potentially reducing the need for more risky procedures and enabling earlier interventions. The impact extends beyond individual patients to healthcare systems, which may benefit from more efficient workflows and reduced costs associated with advanced imaging.
